![metformin jun02][1]
Following the recall of type 2 diabetes medication Metformin Hydrochloride Extended-Release (ER) by Apotex last week, the U.S. Food and Drug Administration or FDA has recommended more pharmaceutical companies, who are manufacturers of the drug formulation, to recall their products.
![fda recall apotex 052920][2]
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
![acellapharma may26][3]
The U.S. Food and Drug Administration or FDA announced that Acella Pharmaceuticals, LLC recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency. The company is recalling 13 lots of NP Thyroid that are packaged in 100 count bottles in strengths of 30 mg, 60 mg, and 90 mg, with expiration dates between June 20, 2020, and December 20, 2020.
![biotabiosciences may21][4]
Biota Biosciences recalled certain lots of pain suppressing medication Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin in the form of injectables as they were marketed without the approval of the U.S. Food and Drug Administration or FDA. Biota Biosciences is a supplier and contract manufacturer of wholesale, private label, and white label CBD Hemp Oil products.
- cdn.rttnews.com/articleimages/ustopstories/2020/june/metformin-jun02.jpg (metformin jun02)
- cdn.rttnews.com/articleimages/ustopstories/2020/may/fda-recall-apotex-052920.jpg (fda recall apotex 052920)
- cdn.rttnews.com/articleimages/ustopstories/2020/may/acellapharma-may26.jpg (acellapharma may26)
- cdn.rttnews.com/articleimages/ustopstories/2020/may/biotabiosciences-may21.jpg (biotabiosciences may21)